| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
100,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
100,000 |
0.00 |
0.00 |
100,000 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
150,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
350,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
350,000 |
0.00 |
0.00 |
350,000 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
700,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
700,000 |
0.00 |
0.00 |
700,000 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
925,000 |
0.00 |
0.00 |
925,000 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
155,090 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - D |
155,090 |
0.00 |
0.00 |
155,090 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
23,786 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
23,786 |
0.00 |
0.00 |
23,786 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
37,296 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
37,296 |
0.00 |
0.00 |
37,296 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
45,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
45,000 |
0.00 |
0.00 |
45,000 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
20,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
20,000 |
0.00 |
0.00 |
20,000 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
117,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
117,000 |
0.00 |
0.00 |
117,000 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
150,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
300,000 |
0.00 |
0.00 |
0 |
| XLO |
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
300,000 |
0.00 |
0.00 |
300,000 |